Latest Lion Point Capital, LP Stock Portfolio
$199Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Lion Point Capital, LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Lion Point Capital, LP reported an equity portfolio of $199.9 Millions as of 31 Dec, 2023.
The top stock holdings of Lion Point Capital, LP are SMTC, MRNS, ARDX. The fund has invested 28.3% of it's portfolio in SEMTECH CORP and 11.6% of portfolio in MARINUS PHARMACEUTICALS INC.
The fund managers got completely rid off DURECT CORP (DRRX) and CHEVRON CORP NEW (CVX) stocks. They significantly reduced their stock positions in SERES THERAPEUTICS INC (MCRB), MIRUM PHARMACEUTICALS INC (MIRM) and BATTALION OIL CORPORATION (BATL). Lion Point Capital, LP opened new stock positions in ENPHYS ACQUISITION CORP (NFYS), AMYLYX PHARMACEUTICALS INC (AMLX) and BURGERFI INTERNATIONAL INC (BFI). The fund showed a lot of confidence in some stocks as they added substantially to MILESTONE PHARMACEUTICALS IN (MIST), HARPOON THERAPEUTICS INC (HARP) and REPLIMUNE GROUP INC (REPL).
The top stock holdings of Lion Point Capital, LP are SMTC, MRNS, ARDX. The fund has invested 28.3% of it's portfolio in SEMTECH CORP and 11.6% of portfolio in MARINUS PHARMACEUTICALS INC.
The fund managers got completely rid off DURECT CORP (DRRX) and CHEVRON CORP NEW (CVX) stocks. They significantly reduced their stock positions in SERES THERAPEUTICS INC (MCRB), MIRUM PHARMACEUTICALS INC (MIRM) and BATTALION OIL CORPORATION (BATL). Lion Point Capital, LP opened new stock positions in ENPHYS ACQUISITION CORP (NFYS), AMYLYX PHARMACEUTICALS INC (AMLX) and BURGERFI INTERNATIONAL INC (BFI). The fund showed a lot of confidence in some stocks as they added substantially to MILESTONE PHARMACEUTICALS IN (MIST), HARPOON THERAPEUTICS INC (HARP) and REPLIMUNE GROUP INC (REPL).
New Buys
| Ticker | $ Bought |
|---|---|
| ENPHYS ACQUISITION CORP | 833,594 |
| AMYLYX PHARMACEUTICALS INC | 206,080 |
| BURGERFI INTERNATIONAL INC | 93,755 |
New stocks bought by Lion Point Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| MILESTONE PHARMACEUTICALS IN | 266 |
| HARPOON THERAPEUTICS INC | 177 |
| REPLIMUNE GROUP INC | 21.43 |
| SEMTECH CORP | 5.1 |
Additions to existing portfolio by Lion Point Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| SERES THERAPEUTICS INC | -50.74 |
| MIRUM PHARMACEUTICALS INC | -50.00 |
| BATTALION OIL CORPORATION | -41.67 |
| ARDELYX INC | -2.12 |
| MARINUS PHARMACEUTICALS INC | -0.51 |
Lion Point Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| DURECT CORP | -1,064,360 |
| CHEVRON CORP NEW | -7,757 |
Lion Point Capital, LP got rid off the above stocks
Current Stock Holdings of Lion Point Capital, LP
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AADI | AADI BIOSCIENCE INC | 0.08 | 82,423 | 166,494 | UNCHANGED | 0.00 | |
| ACRS | ACLARIS THERAPEUTICS INC | 0.06 | 115,898 | 121,693 | UNCHANGED | 0.00 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.10 | 14,000 | 206,080 | NEW | ||
| ARDX | ARDELYX INC | 3.57 | 1,151,670 | 7,140,340 | REDUCED | -2.12 | |
| AVDL | AVADEL PHARMACEUTICALS PLC | 0.56 | 80,000 | 1,129,600 | UNCHANGED | 0.00 | |
| BATL | BATTALION OIL CORPORATION | 1.07 | 222,182 | 2,135,170 | REDUCED | -41.67 | |
| BFI | BURGERFI INTERNATIONAL INC | 1.18 | 2,745,940 | 2,361,230 | UNCHANGED | 0.00 | |
| BFI | BURGERFI INTERNATIONAL INC | 0.05 | 2,083,440 | 93,755 | NEW | ||
| BLUE | BLUEBIRD BIO INC | 0.37 | 531,256 | 733,133 | UNCHANGED | 0.00 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.97 | 82,425 | 1,946,880 | UNCHANGED | 0.00 | |
| CVX | CHEVRON CORP NEW | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| DRRX | DURECT CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FENC | FENNEC PHARMACEUTICALS INC | 0.62 | 110,000 | 1,234,200 | UNCHANGED | 0.00 | |
| GOOG | ALPHABET INC | 0.01 | 100 | 14,093 | UNCHANGED | 0.00 | |
| HARP | HARPOON THERAPEUTICS INC | 1.30 | 228,900 | 2,602,590 | ADDED | 177 | |
| HUMA | HUMACYTE INC | 0.33 | 235,000 | 667,400 | UNCHANGED | 0.00 | |
| INSM | INSMED INC | 1.09 | 70,335 | 2,179,680 | UNCHANGED | 0.00 | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | 1.15 | 130,691 | 2,292,320 | UNCHANGED | 0.00 | |
| LUMO | LUMOS PHARMA INC | 0.14 | 90,794 | 288,725 | UNCHANGED | 0.00 | |
| MCRB | SERES THERAPEUTICS INC | 0.24 | 340,761 | 477,065 | REDUCED | -50.74 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.20 | 13,500 | 398,520 | REDUCED | -50.00 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 1.38 | 1,650,210 | 2,755,850 | ADDED | 266 | |
| MRNS | MARINUS PHARMACEUTICALS INC | 11.61 | 2,134,340 | 23,200,200 | REDUCED | -0.51 | |
| MSFT | MICROSOFT CORP | 0.02 | 100 | 37,604 | UNCHANGED | 0.00 | |
| NFYS | ENPHYS ACQUISITION CORP | 0.42 | 78,125 | 833,594 | NEW | ||
| REPL | REPLIMUNE GROUP INC | 0.18 | 42,500 | 358,275 | ADDED | 21.43 | |
| SMTC | SEMTECH CORP | 28.26 | 2,577,860 | 56,480,800 | ADDED | 5.1 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.37 | 34,500 | 745,545 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.35 | 78,000 | 701,220 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.34 | 1,000,000 | 670,740 | UNCHANGED | 0.00 |